News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Expanded CRISPR toolkit includes Cpf1 and range of Alt-R™ support products, increasing the options available to molecular biology researchers CORALVILLE, IA (February 1, 2017) – Reflecting its drive to provide innovative solutions to the genomics community, Integrated DNA Technologies (IDT) is the first genomics company to develop and bring to market a complete ribonucleoprotein-based Cpf1... Read more
Combines award-winning Chromium™ System from 10x Genomics with PerkinElmer’s state-of-the-art automation solutions PLEASANTON, Calif., January 9, 2017 – 10x Genomics, Inc., a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced they and PerkinElmer, Inc. will jointly offer automated next-generation sequencing (NGS) solutions. PerkinElmer’s automation solutions increase both the throughput... Read more
Development of a high-performance tool set for human and mouse genetic screens to enable enhanced drug discovery underway NEWS PROVIDED BY Cellecta, Inc. 26 Jan, 2017, 08:40 ET SHARE THIS ARTICLE MOUNTAIN VIEW, Calif., Jan. 26, 2017 /PRNewswire/ — Cellecta, Inc. today announced the receipt of Phase II SBIR grant funds from the National Institute of... Read more
U.S. Patent and Trademark Office finds U.S. Patent No. 8,658,430 invalid in inter partes review PLEASANTON, Calif., January 20, 2017 – 10x Genomics, Inc. today announced that the company has prevailed in an inter partes review proceeding before the U.S. Patent and Trademark Office to invalidate U.S. Patent No. 8,658,430 owned by RainDance Technologies, Inc.... Read more
Takara Bio USA Holdings, Inc. completes acquisition of Rubicon Genomics, Inc. Mountain View, CA—January 18, 2017—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of Rubicon Genomics, Inc. (“Rubicon”), Rubicon has become a wholly-owned subsidiary of TBUSH as of January 17, 2017 (US local time). Under the merger agreement executed with Rubicon,... Read more
Congenica Expands in North America with Strategic Appointment Shikha O’Brien, Chief Business Officer Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer 16th January 2017, Cambridge UK Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited Dr Shikha... Read more
HERCULES, Calif. — January 16, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, announced today that it has entered into a definitive agreement to purchase RainDance Technologies, Inc. The terms of the acquisition were not disclosed. Bio-Rad expects the transaction to close during... Read more
MENLO PARK, Calif., and BEIJING, Jan. 16, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) and Novogene Corporation, a leading provider of genomic and bioinformatic services, today announced that Novogene has agreed to purchase 10 Sequel™ Systems for whole genome sequencing, Iso-Seq™ annotation and targeted sequencing services.PacBio’s sequencing systems are based on its... Read more
MENLO PARK, Calif., Jan. 12, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced that its Single Molecule, Real-Time (SMRT®) Sequencing technology will be featured in at least 57 podium presentations and 60 posters at the International Plant & Animal Genome (PAG) XXV Conference taking place January 14-18 in San Diego, California. From specialty beverage... Read more
SAN DIEGO and HERCULES, Calif. — January 9, 2017 — Illumina, Inc. (NASDAQ: ILMN) and Bio‑Rad Laboratories, Inc. (NYSE: BIO)(NYSE: BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference, San Francisco. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers... Read more